跳至主要内容
临床试验/CTRI/2024/09/073664
CTRI/2024/09/073664尚未招募不适用

The Role Of Individualized Homoeopathic Medicine In LM Potency For The Management Of Hypothyroidism

Dr. Pooja Sojitra1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年10月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
1. Individualized Homoeopathic Medicines in LM Potencies are effective in Hypothyroidism.

研究概览

简要总结

This study aims to evaluate the efficacy of individualized homoeopathic medicine in LM potency for the management of hypothyroidism. 40 patients with hypothyroidism will be recruited and treated with individualized homoeopathic medicine in LM potency for 1 year duration.The primary outcome measure will be the change in thyroid-stimulating hormone (TSH) levels  as well as symptom improvement.The study will assess the effectiveness of individualized homoeopathic medicine in LM potency as a treatment option for hypothyroidism.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Pre-diagnosed cases and diagnosed cases of Hypothyroidism having increase TSH level.
  • 2.Any sex, religion or socioeconomic status Willing to participate in the study and provide informed consent.

排除标准

  • 1.Patients with secondary or tertiary hypothyroidism or those with hypothyroidism secondary to a surgical or radiation-induced cause.
  • 2.Patient taking any other mode of treatment.
  • 3.Pregnant and lactating women.

结局指标

主要结局

1. Individualized Homoeopathic Medicines in LM Potencies are effective in Hypothyroidism.

时间窗: 15 days

2. Reduction of symptoms of Hypothyroidism.

时间窗: 15 days

3. Will measure the change in thyroid-stimulating hormone (TSH) levels.

时间窗: 15 days

次要结局

  • To assess treatment outcome in cases of Hypothyroidism using Zulewski’s clinical(score.)

研究者

发起方
Dr. Pooja Sojitra
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Pooja Sojitra

Jawaharlal Nehru Homoeopathic Medical College

研究点 (1)

Loading locations...

相似试验

Role of Individualized Homoeopathic Medicine in LM... | 临床试验